Citations (156)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (38)
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín & M. J. Cancelo. (2023) Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA. Climacteric 26:5, pages 437-444.
Read now
Read now
Rossella E. Nappi & Rod Baber. (2023) What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the ‘silent suffering’ of postmenopausal women with genitourinary symptoms?. Climacteric 26:4, pages 289-291.
Read now
Read now
Andrea R. Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Pharmacotherapeutic options for the treatment of menopausal symptoms. Expert Opinion on Pharmacotherapy 22:13, pages 1773-1791.
Read now
Read now
X. Ruan, L. Zhang, Y. Cui, M. Gu & A. O. Mueck. (2021) Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women. Climacteric 24:3, pages 297-304.
Read now
Read now
Rossella E. Nappi, Maurizio Guida, Diego Marchesoni, Antonio Cianci, Antonio Pellegrino, Valentino Remorgida, Tiziana Di Paolantonio & Pierluigi Benedetti Panici. (2021) Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women. Journal of Obstetrics and Gynaecology 41:2, pages 290-297.
Read now
Read now
R. E. Nappi, M. Kotek, A. Brešt’anský, N. Giordan & E. Tramentozzi. (2020) Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric 23:5, pages 519-524.
Read now
Read now
F. Murina, R. Felice, S. Di Francesco, L. Nelvastellio & I. Cetin. (2020) Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain. Gynecological Endocrinology 36:5, pages 431-435.
Read now
Read now
R. Flint, L. Cardozo, T. Grigoriadis, A. Rantell, E. Pitsouni & S. Athanasiou. (2019) Rationale and design for fractional microablative CO2 laser versus
photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of
menopause: a non-inferiority, single-blind randomized controlled trial. Climacteric 22:3, pages 307-311.
Read now
Read now
R. E. Nappi, R. Seracchioli, S. Salvatore, A. Cagnacci, T. Di Paolantonio & M. Busacca. (2019) Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study. Gynecological Endocrinology 35:5, pages 453-459.
Read now
Read now
J. A. Simon, S. R. Davis, S. E. Althof, P. Chedraui, A. H. Clayton, S. A. Kingsberg, R. E. Nappi, S. J. Parish & W. Wolfman. (2018) Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric 21:5, pages 415-427.
Read now
Read now
R. E. Nappi, N. R. de Melo, M. Martino, C. Celis-González, P. Villaseca, S. Röhrich & S. Palacios. (2018) Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America. Climacteric 21:4, pages 397-403.
Read now
Read now
Filippo Murina, Stefania Di Francesco & Silvia Oneda. (2018) Vulvar vestibular effects of ospemifene: a pilot study. Gynecological Endocrinology 34:7, pages 631-635.
Read now
Read now
S. Palacios, R. E. Nappi, N. Bruyniks, M. Particco & N. Panay. (2018) The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric 21:3, pages 286-291.
Read now
Read now
E. Moral, J. L. Delgado, F. Carmona, B. Caballero, C. Guillán, P. M. González, J. Suárez-Almarza, S. Velasco-Ortega & C. Nieto. (2018) Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric 21:2, pages 167-173.
Read now
Read now
M. Yaralizadeh, P. Abedi & P. Salehinejad. (2017) Relationship between delivery modes and genitourinary syndrome among postmenopausal women. Climacteric 20:4, pages 362-366.
Read now
Read now
N. Bruyniks, N. Biglia, S. Palacios & A. O. Mueck. (2017) Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy. Climacteric 20:3, pages 195-204.
Read now
Read now
Rossella E. Nappi, Martire Particco, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2017) Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data. Gynecological Endocrinology 33:5, pages 389-394.
Read now
Read now
E. Fooladi, M. Deldar, F. Mohammadzadeh, E. Ahmadnia, S. Khani & Z. Ghanbari. (2017) Iranian postmenopausal women’s experiences of treatment of symptomatic vulvovaginal atrophy. Climacteric 20:1, pages 67-71.
Read now
Read now
S. Palacios, M. J. Cancelo, C. Castelo Branco, P. Llaneza, F. Molero & R. Sanchez Borrego. (2017) Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions. Climacteric 20:1, pages 55-61.
Read now
Read now
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
F. Palma, E. Della Vecchia & A. Cagnacci. (2016) Medical and patient attitude towards vaginal atrophy: the AGATA study. Climacteric 19:6, pages 553-557.
Read now
Read now
Rossella E. Nappi, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2016) Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group. Gynecological Endocrinology 32:8, pages 602-606.
Read now
Read now
R. E. Nappi & M. L. Krychman. (2016) The American–European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey. Climacteric 19:3, pages 252-255.
Read now
Read now
R. E. Nappi, S. Palacios, N. Panay, M. Particco & M. L. Krychman. (2016) Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 19:2, pages 188-197.
Read now
Read now
N. Bruyniks, R. E. Nappi, C. Castelo-Branco, T. J. de Villiers & J. Simon. (2016) Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric 19:1, pages 60-65.
Read now
Read now
JoAnn V Pinkerton & Risa Kagan. (2015) Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use. Expert Opinion on Pharmacotherapy 16:17, pages 2703-2714.
Read now
Read now
F. Labrie, M. Montesino, D. F. Archer, L. Lavoie, A. Beauregard, I. Côté, C. Martel, M. Vaillancourt, J. Balser & E. Moyneur. (2015) Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner. Climacteric 18:6, pages 817-825.
Read now
Read now
M. Gambacciani, M. G. Torelli, L. Martella, G. L. Bracco, A. G. Casagrande, E. Albertin, S. Tabanelli, M. Viglietta, G. D’Ambrogio, G. Garone & M. Cervigni. (2015) Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric 18:sup1, pages 43-48.
Read now
Read now
M. Gambacciani, M. Levancini & M. Cervigni. (2015) Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 18:5, pages 757-763.
Read now
Read now
B. M. Zeleke, S. R. Davis, P. Fradkin & R. J. Bell. (2015) Vasomotor symptoms and urogenital atrophy in older women: a systematic review. Climacteric 18:2, pages 112-120.
Read now
Read now
R. E. Nappi, N. Panay, N. Bruyniks, C. Castelo-Branco, T. J. De Villiers & J. A. Simon. (2015) The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. Climacteric 18:2, pages 233-240.
Read now
Read now
S. Salvatore, R. E. Nappi, M. Parma, R. Chionna, F. Lagona, N. Zerbinati, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2015) Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 18:2, pages 219-225.
Read now
Read now
R.J. Levin. (2015) Sexuality of the ageing female – the underlying physiology. Sexual and Relationship Therapy 30:1, pages 25-36.
Read now
Read now
Mary Jane Minkin, Ricardo Maamari & Suzanne Reiter. (2014) Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy. International Journal of Women's Health 6, pages 281-288.
Read now
Read now
D. J. Portman & M. L. S. Gass. (2014) Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 17:5, pages 557-563.
Read now
Read now
S. Salvatore, R. E. Nappi, N. Zerbinati, A. Calligaro, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17:4, pages 363-369.
Read now
Read now
J. E. Blümel, P. Chedraui, G. Barón, Z. Benítez, D. Flores, M. T. Espinoza, G. Gomez, E. González, L. Hernández, S. Lima, M. Martino, A. Montaño, A. Monterrosa, D. Mostajo, E. Ojeda, W. Onatra, C. Robles, J. Saavedra, H. Sánchez, K. Tserotas, M. S. Vallejo & C. Vallejo. (2014) A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 17:4, pages 433-441.
Read now
Read now
R. E. Nappi & S. Palacios. (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17:1, pages 3-9.
Read now
Read now
Articles from other publishers (118)
Anna Gosset, Jeanne Marie Claeys, Eric Huyghe & Florence Tremollieres. (2023) Sexual function and quality of life in women with idiopathic premature ovarian insufficiency. The Journal of Sexual Medicine 20:5, pages 626-632.
Crossref
Crossref
Nur Hilwani Ismail, Siti Fatimah Ibrahim, Mohd Helmy Mokhtar, Azyani Yahaya, Aini Farzana Zulkefli, Sheril June Ankasha & Khairul Osman. (2023) Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats. Frontiers in Endocrinology 14.
Crossref
Crossref
Daniela Gold, Laura Nicolay, Alexander Avian, Elfriede Greimel, Marija Balic, Gunda Pristauz-Telsnigg, Karl Tamussino & Gerda Trutnovsky. (2023) Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial. Maturitas 167, pages 1-7.
Crossref
Crossref
Tiziana Fidecicchi, Marisa Ardito, Andrea Giannini, Tommaso Simoncini & Andrea R. Genazzani. 2023. Amenorrhea. Amenorrhea
179
192
.
Remi Yoshikata, Michiko Yamaguchi, Yuri Mase, Ayano Tatsuyuki, Khin Zay Yar Myint & Hiroaki Ohta. (2022) Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial. PLOS ONE 17:12, pages e0270242.
Crossref
Crossref
Rossella E. NAPPI, Miroslav KOTEK, Alexander BREŠTÁNSKÝ, Nicola GIORDAN, Irene BERIOTTO & Elisa TRAMENTOZZI. (2022) Treatment of vulvo-vaginal atrophy with hyaluronate-based gel: a randomized controlled study. Minerva Obstetrics and Gynecology 74:6.
Crossref
Crossref
Masakazu Terauchi, Tamami Odai, Kiyoko Kato & Naoyuki Miyasaka. (2022) Body weight and body fat are negatively associated with severe dyspareunia in postmenopausal women. Journal of Obstetrics and Gynaecology Research 48:12, pages 3279-3285.
Crossref
Crossref
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach & Evgeny D. Dolgov. (2022) Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life. Gynecology 24:5, pages 408-412.
Crossref
Crossref
Hanna Surmann & Ludwig Kiesel. (2022) Vaginale CO2-Laserbehandlung bei postmenopausalen FrauenVaginal CO2 laser therapy for postmenopausal women. Die Gynäkologie 55:10, pages 794-798.
Crossref
Crossref
Sarah Cipriani & James A. Simon. (2022) Sexual Dysfunction as a Harbinger of Cardiovascular Disease in Postmenopausal Women: How Far Are We?. The Journal of Sexual Medicine 19:9, pages 1321-1332.
Crossref
Crossref
Rossella E. Nappi, Silvia Martella, Francesca Albani, Chiara Cassani, Ellis Martini & Fabio Landoni. (2022) Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?. Healthcare 10:8, pages 1528.
Crossref
Crossref
Angela Gregory. (2022) Female sexual dysfunction: what the practice nurse needs to know. Practice Nursing 33:8, pages 318-323.
Crossref
Crossref
Meichen Liu, Fengyong Li, Yu Zhou, Yujiao Cao, Senkai Li & Qiang Li. (2021)
Efficacy of CO
2
laser treatment in postmenopausal women with vulvovaginal atrophy: A meta‐analysis
. International Journal of Gynecology & Obstetrics 158:2, pages 241-251.
Crossref
Crossref
Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
Crossref
Dana Gabrieli, Yael Suissa-Cohen, Sireen Jaber & Ahinoam Lev-Sagie. (2022) “Modified Schirmer Test” as an Objective Measurement for Vaginal Dryness: A Prospective Cohort Study. Diagnostics 12:3, pages 574.
Crossref
Crossref
Pooja A.Pachani, Rajendra R. Godbole, Jeevitaa Kshersagar, Rakhi Jagdale, Amita Gosavi, Somshekhar Patil, Rakesh k Sharma & Meghnad G. Joshi. (2022) A comparative study of smica in various body fluids of diagnosed cervical cancer patients and healthy women. Obstetrics & Gynecology Science 65:1, pages 37-45.
Crossref
Crossref
Laura Porterfield, Nyajuok WurZuleica Santiago DelgadoFarha SyedAmanda SongSusan C. Weller. (2022) Vaginal Vitamin E for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review of Randomized Controlled Trials. Journal of Menopausal Medicine 28:1, pages 9.
Crossref
Crossref
Bijun Kang, Yizuo Cai, Zhuoxuan Jia, Chingyu Chen, Mingwu Deng, Wenjie Zhang & Wei Li. (2022) Cell-Free Fat Extract Prevents Vaginal Atrophy in an Ovariectomized Model by Promoting Proliferation of Vaginal Keratinocytes and Neovascularization. Aesthetic Surgery Journal 42:1, pages NP55-NP68.
Crossref
Crossref
Helena Slongo, Ana Lygia B. Lunardi, Cássio L. Z. Riccetto, Helymar C. Machado & Cássia R. T. Juliato. (2021) Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. International Urogynecology Journal 33:1, pages 53-64.
Crossref
Crossref
Avitus John Raakesh Prasad, Ganesh S. Pai & Anusha H. Pai. 2022. Aesthetic and Regenerative Gynecology. Aesthetic and Regenerative Gynecology
53
66
.
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment
71
79
.
Rossella E. Nappi, Laura Cucinella, Ellis Martini & Chiara Cassani. (2021) The role of hormone therapy in urogenital health after menopause. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101595.
Crossref
Crossref
Wendy Wolfman, Yonah Krakowsky & Michel Fortier. (2021) Directive clinique no 422d : Ménopause et sexualité. Journal of Obstetrics and Gynaecology Canada 43:11, pages 1342-1351.e1.
Crossref
Crossref
Wendy Wolfman, Yonah Krakowsky & Michel Fortier. (2021) Guideline No. 422d: Menopause and Sexuality. Journal of Obstetrics and Gynaecology Canada 43:11, pages 1334-1341.e1.
Crossref
Crossref
Andrea R Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update 27:6, pages 1115-1150.
Crossref
Crossref
Alessandro F. Ruffolo, Arianna Casiraghi, Elena Marotta, Rebecca Degliuomini, Marta Parma, Stavros Athanasiou, Vittoria Benini, Massimo Candiani & Stefano Salvatore. (2021)
Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
2
Laser Efficacy in Postmenopausal Women?
. Lasers in Surgery and Medicine 53:7, pages 953-959.
Crossref
Crossref
Kirsti ToivonenPablo Santos-IglesiasLauren M. Walker. (2021) Impact of Vulvovaginal Symptoms in Women Diagnosed with Cancer: A Psychometric Evaluation of the Day-to-Day Impact of Vaginal Aging Questionnaire. Journal of Women's Health 30:8, pages 1192-1203.
Crossref
Crossref
Michaela Gabes, Petra Stute & Christian Apfelbacher. (2021) Validation of the German Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire in Peri- and Postmenopausal Women. Sexual Medicine 9:4, pages 100382-100382.
Crossref
Crossref
Gian Piero Siliquini, Valentina Elisabetta Bounous, Lorenzo Novara, Margherita Giorgi, Fabrizio Bert & Nicoletta Biglia. (2021) Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. The Breast Journal 27:5, pages 448-455.
Crossref
Crossref
Alyssa N. Gardner & Sarit O. Aschkenazi. (2021) The short-term efficacy and safety of fractional CO2 laser therapy for vulvovaginal symptoms in menopause, breast cancer, and lichen sclerosus. Menopause 28:5, pages 511-516.
Crossref
Crossref
Francesco De Seta, Salvatore Caruso, Giovanni Di Lorenzo, Federico Romano, Mariateresa Mirandola & Rossella E. Nappi. (2021) Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. Maturitas 147, pages 34-40.
Crossref
Crossref
I-Hsuan Yang, I-En Lin, Tzu-Chien Chen, Zhi-Yu Chen, Che-Yung Kuan, Jhih-Ni Lin, Yu-Chia Chou & Feng-Huei Lin. (2021) Synthesis, characterization, and evaluation of BDDE crosslinked chitosan-TGA hydrogel encapsulated with genistein for vaginal atrophy. Carbohydrate Polymers 260, pages 117832.
Crossref
Crossref
Marisa Liu, Mark Juravic, Genevieve Mazza & Michael L. Krychman. (2021) Vaginal Dilators: Issues and Answers. Sexual Medicine Reviews 9:2, pages 212-220.
Crossref
Crossref
Jing Wang & Ling Wang. (2021) The therapeutic effect of dehydroepiandrosterone (DHEA) on vulvovaginal atrophy. Pharmacological Research 166, pages 105509.
Crossref
Crossref
Ying Sheng, Janet Carpenter, Andrea Cohee, Susan Storey, Timothy Stump, Patrick Monahan, David Cella & Victoria Champion. (2021) Genitourinary Symptoms in Breast Cancer Survivors: Prevalence, Correlates, and Relationship With Sexual Functioning. Oncology Nursing Forum 48:2, pages 229-241.
Crossref
Crossref
Fiona Li, Vanessa Picard-Fortin, Sarah Maheux-Lacroix, Rebecca Deans, Erin Nesbitt-Hawes, Lalla McCormack & Jason Abbott. (2021) The Efficacy of Vaginal Laser and Other Energy-based Treatments on Genital Symptoms in Postmenopausal Women: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology 28:3, pages 668-683.
Crossref
Crossref
Joshua Morris, Cassidy Clark, Laura Reed, Diane Pace, Xueyuan Cao & Pallavi Khanna. (2021) Healthcare provider knowledge, attitudes, and preferences in management of genitourinary syndrome of menopause in the Mid-South. Menopause 28:11, pages 1239-1246.
Crossref
Crossref
Michaela Gabes, Petra Stute & Christian J. Apfelbacher. (2021) Refinement of the German Day-to-Day Impact of Vaginal Aging questionnaire in perimenopausal and postmenopausal women using item response theory and classical test theory. Menopause 28:3, pages 292-299.
Crossref
Crossref
Richard Flint & Cathy Davis. 2021. Sexual Function and Pelvic Floor Dysfunction. Sexual Function and Pelvic Floor Dysfunction
65
81
.
Makeba Williams. 2021. Challenges in Older Women’s Health. Challenges in Older Women’s Health
1
14
.
Alison Bealle Rudd & Anjanetta Davis. (2020) A Call to Change the Narrative on Genitourinary Syndrome of Menopause. Nursing for Women's Health 24:6, pages 399-403.
Crossref
Crossref
Shannon L. Wallace, Brad St Martin, Kyueun Lee & Eric R. Sokol. (2020) A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia. American Journal of Obstetrics and Gynecology 223:6, pages 890.e1-890.e12.
Crossref
Crossref
X. Gamé & V. Phé. (2020) Syndrome clinique d’hyperactivité vésicale non neurologique et pathologie pelvi-périnéale de la femme. Progrès en Urologie 30:14, pages 887-894.
Crossref
Crossref
Peter Takacs, Attila Gergely Sipos, Bence Kozma, Tina D. Cunningham, Kindra Larson, Rudolf Lampé & Robert Poka. (2020)
The Effect of Vaginal Microablative Fractional CO
2
Laser Treatment on Vaginal Cytology
. Lasers in Surgery and Medicine 52:8, pages 708-712.
Crossref
Crossref
Claudine Domoney, Hannah Short, Martire Particco & Nick Panay. (2020) Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study. Post Reproductive Health 26:2, pages 101-109.
Crossref
Crossref
L. Photiou, M.J. Lin, D.P. Dubin, V. Lenskaya & H. Khorasani. (2020) Review of non‐invasive vulvovaginal rejuvenation. Journal of the European Academy of Dermatology and Venereology 34:4, pages 716-726.
Crossref
Crossref
Martire Particco, Stora Djumaeva, Rossella E. Nappi, Nick Panay & Santiago Palacios. (2020) The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause. Menopause 27:4, pages 423-429.
Crossref
Crossref
Diane Todd Pace, Lisa Astalos Chism, Shelli Graham & Julia Amadio. (2020) How Nurse Practitioners Approach Treatment of Genitourinary Syndrome of Menopause. The Journal for Nurse Practitioners 16:2, pages 136-142.
Crossref
Crossref
James A. Simon. (2020) Depression, anxiety, and “the incredible shrinking vagina”∗. Menopause 27:2, pages 125-126.
Crossref
Crossref
Marie Fidela R. Paraiso, Cecile A. Ferrando, Eric R. Sokol, Charles R. Rardin, Catherine A. Matthews, Mickey M. Karram & Cheryl B. Iglesia. (2020) A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Menopause 27:1, pages 50-56.
Crossref
Crossref
Giovanni Cannarozzo, Steven Paul Nisticò, Keyvan Nouri & Mario SanninoGiovanni Cannarozzo, Steven Paul Nisticò, Keyvan Nouri & Mario Sannino. 2020. Atlas of Lasers and Lights in Dermatology. Atlas of Lasers and Lights in Dermatology
87
98
.
Mohammed Belal, Amerdip Birring, Steve Wai Hee Chan, Matthew Crockett, Cosimo De Nunzio, Manuel Castanheira de Oliveira, Aniket Deshpande, Marcus Drake, Vinnie During, Frederico Furriel, Andrea Giannini, Kwang Jin Ko, Kyu-Sung Lee, Amit Mevcha, Luis Abranches Monteiro, André Marques Pinto, Martin Romancik & Andrea Tubaro. 2020. Lower Urinary Tract Symptoms in Adults. Lower Urinary Tract Symptoms in Adults
131
167
.
Attila Gergely Sipos, Bence Kozma, Robert Poka, Kindra Larson & Peter Takacs. (2019)
The Effect of Fractional CO
2
Laser Treatment on the Symptoms of Pelvic Floor Dysfunctions: Pelvic Floor Distress Inventory‐20 Questionnaire
. Lasers in Surgery and Medicine 51:10, pages 882-886.
Crossref
Crossref
Michaela Gabes, Helge Knüttel, Petra StuteChristian J. Apfelbacher. (2019) Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review. Menopause 26:11, pages 1342-1353.
Crossref
Crossref
Brooke M Faught, Graziella Soulban, Jason Yeaw, Christiane Maroun, Katharine Coyle, Samuel Schaffer & Mitch DeKoven. (2019) Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia. Journal of Comparative Effectiveness Research 8:13, pages 1111-1123.
Crossref
Crossref
Risa Kagan, Susan Kellogg-Spadt & Sharon J. Parish. (2019) Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs & Aging 36:10, pages 897-908.
Crossref
Crossref
Rossella E. Nappi, Ellis Martini, Laura Cucinella, Silvia Martella, Lara Tiranini, Alessandra Inzoli, Emanuela Brambilla, David Bosoni, Chiara Cassani & Barbara Gardella. (2019) Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. Frontiers in Endocrinology 10.
Crossref
Crossref
Raymond J. LanzafameSarah de la TorreGustavo H. Leibaschoff. (2019) The Rationale for Photobiomodulation Therapy of Vaginal Tissue for Treatment of Genitourinary Syndrome of Menopause: An Analysis of Its Mechanism of Action, and Current Clinical Outcomes. Photobiomodulation, Photomedicine, and Laser Surgery 37:7, pages 395-407.
Crossref
Crossref
Joanie Mercier, Mélanie Morin, Barbara Reichetzer, Marie-Claude Lemieux, Samir Khalifé & Chantale Dumoulin. (2019) Genitourinary syndrome of menopause symptom severity and impact outcome measures: are they reliable and correlated?. Menopause 26:6, pages 659-664.
Crossref
Crossref
Santiago Palacios, Silvia P. González, Micaela Fernández-Abellán, Montserrat Manubens, Pascual García-Alfaro, C.Argudo Prieto, L.Baquedano Mainar, J.Calleja Abu-Amshah, M.J.Cancelo Hidalgo, C. Castelo-Branco i Flores, P.Coronado Martin, M.Correa Rancel, M.Fernández Abellán, J.M.Fernández Moya, P.García Alfaro, M.González Fernández, S.González Rodríguez, E.Iglesias Bravo, P.Llaneza Coto, M.Manubens Grau, P.Marín Sánchez, N.Mendoza Ladrón de Guevara, B.Otero García-Ramos, S. Palacios, J.C.Presa Lorite, R.Sánchez Borrego, S.Sánchez Méndez & F.Vázquez Fernández. (2019) Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study. Sexual Medicine 7:2, pages 207-216.
Crossref
Crossref
Rossella E. Nappi, Santiago Palacios, Nico Bruyniks, Martire Particco & Nick Panay. (2019) The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey. Menopause 26:5, pages 485-491.
Crossref
Crossref
Sharon J. Parish, Steven R. Hahn, Sue W. Goldstein, Annamaria Giraldi, Sheryl A. Kingsberg, Lisa Larkin, Mary Jane Minkin, Vivien Brown, Kristin Christiansen, Rose Hartzell-Cushanick, Alyse Kelly-Jones, Jordan Rullo, Richard Sadovsky & Stephanie S. Faubion. (2019) The International Society for the Study of Women's Sexual Health Process of Care for the Identification of Sexual Concerns and Problems in Women. Mayo Clinic Proceedings 94:5, pages 842-856.
Crossref
Crossref
Elena Fasola & David Bosoni. (2019) Dynamic Quadripolar Radiofrequency: Pilot Study of a New High-Tech Strategy for Prevention and Treatment of Vulvar Atrophy. Aesthetic Surgery Journal 39:5, pages 544-552.
Crossref
Crossref
Sharon J. Parish, Cindy M. Meston, Stanley E. Althof, Anita H. Clayton, Irwin Goldstein, Sue W. Goldstein, Julia R. Heiman, Marita P. McCabe, R. Taylor Segraves & James A. Simon. (2019) Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part III. The Journal of Sexual Medicine 16:3, pages 452-462.
Crossref
Crossref
Sheryl A. Kingsberg, Lisa Larkin, Michael Krychman, Sharon J. Parish, Brian Bernick & Sebastian Mirkin. (2019) WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history. Menopause 26:2, pages 124-131.
Crossref
Crossref
Eloy Moral, Juan L. Delgado, Francisco Carmona, Borja Caballero, Cristina Guillán, Paula M. González, Javier Suárez-AlmarzaSyra Velasco-OrtegaConcepción Nieto Magro. (2018) The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause 25:12, pages 1418-1423.
Crossref
Crossref
Raffaela Di Pace & Rosalba Portuesi. (2018) Vaginal health index score and urogenital syndrome of menopause. Gazzetta Medica Italiana Archivio per le Scienze Mediche 177:12.
Crossref
Crossref
Ashley L. Hodges, Aimee C. Holland, Barbara Dehn & Diane T. Pace. (2018) Diagnosis and Treatment of Genitourinary Syndrome of Menopause. Nursing for Women's Health 22:5, pages 423-430.
Crossref
Crossref
Sharon J. Parish, Rossella E. Nappi & Sheryl Kingsberg. (2018) Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment. Menopause 25:8, pages 937-949.
Crossref
Crossref
James A. Simon, Irwin Goldstein, Noel N. Kim, Susan R. Davis, Susan Kellogg-Spadt, Lior Lowenstein, JoAnn V. Pinkerton, Cynthia A. Stuenkel, Abdulmaged M. Traish, David F. Archer, Gloria Bachmann, Andrew T. Goldstein, Rossella E. Nappi & Linda Vignozzi. (2018) The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause 25:7, pages 837-847.
Crossref
Crossref
Patrizia Monteleone, Giulia Mascagni, Andrea Giannini, Andrea R. Genazzani & Tommaso Simoncini. (2018) Symptoms of menopause — global prevalence, physiology and implications. Nature Reviews Endocrinology 14:4, pages 199-215.
Crossref
Crossref
Andrea Giannini, Eleonora Russo, Antonio Cano, Peter Chedraui, Dimitrios G. Goulis, Irene Lambrinoudaki, Patrice Lopes, Gita Mishra, Alfred Mueck, Margaret Rees, Levent M. Senturk, John C. Stevenson, Petra Stute, Pauliina Tuomikoski & Tommaso Simoncini. (2018) Current management of pelvic organ prolapse in aging women: EMAS clinical guide. Maturitas 110, pages 118-123.
Crossref
Crossref
Ali A Qureshi, Marissa M Tenenbaum & Terence M Myckatyn. (2018) Nonsurgical Vulvovaginal Rejuvenation With Radiofrequency and Laser Devices: A Literature Review and Comprehensive Update for Aesthetic Surgeons. Aesthetic Surgery Journal 38:3, pages 302-311.
Crossref
Crossref
Eric R. Sokol. (2018) Response to letter to editor. Menopause 25:2, pages 243-244.
Crossref
Crossref
Federica Palma, Anjeza Xholli & Angelo Cagnacci. (2018) The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas 108, pages 18-23.
Crossref
Crossref
Ludwig Kiesel & Annemarie Kohl. (2017) Klinische Relevanz des urogenitalen Syndroms der MenopauseThe clinical relevance of genitourinary syndrome of menopause. Gynäkologische Endokrinologie 15:4, pages 319-327.
Crossref
Crossref
James A. Simon, David F. Archer, Risa Kagan, Brian Bernick, Shelli Graham, Ginger D. ConstantineSebastian Mirkin. (2017) Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial. Menopause 24:9, pages 1003-1010.
Crossref
Crossref
Cara Stabile, Shari Goldfarb, Raymond E. Baser, Deborah J. Goldfrank, Nadeem R. Abu-Rustum, Richard R. Barakat, Maura N. Dickler & Jeanne Carter. (2017) Sexual health needs and educational intervention preferences for women with cancer. Breast Cancer Research and Treatment 165:1, pages 77-84.
Crossref
Crossref
Marco Gambacciani & Santiago Palacios. (2017) Laser therapy for the restoration of vaginal function. Maturitas 99, pages 10-15.
Crossref
Crossref
Kathryn E. Flynn, Jeanne Carter, Li Lin, Stacy T. Lindau, Diana D. Jeffery, Jennifer Barsky Reese, Bethanee J. Schlosser & Kevin P. Weinfurt. (2017) Assessment of vulvar discomfort with sexual activity among women in the United States. American Journal of Obstetrics and Gynecology 216:4, pages 391.e1-391.e8.
Crossref
Crossref
Maurizio FilippiniEster Del DucaFrancesca NegosantiDiletta BoncianiLuca NegosantiMario SanninoGiovanni CannarozzoSteven Paul Nisticò. (2017)
Fractional CO
2
Laser: From Skin Rejuvenation to Vulvo-Vaginal Reshaping
. Photomedicine and Laser Surgery 35:3, pages 171-175.
Crossref
Crossref
Michael Krychman, Shelli Graham, Brian Bernick, Sebastian Mirkin & Sheryl A. Kingsberg. (2017) The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. The Journal of Sexual Medicine 14:3, pages 425-433.
Crossref
Crossref
Sheryl A. Kingsberg, Michael Krychman, Shelli Graham, Brian Bernick & Sebastian Mirkin. (2017) The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment. The Journal of Sexual Medicine 14:3, pages 413-424.
Crossref
Crossref
Sônia Maria Rolim Rosa Lima, Adriana Bittencourt Campaner & Antonio Pedro Flores Auge. (2017) Isoflavones derived from Glycine max (L.) Merr. in the treatment of vaginal atrophy: A new frontier. Revista da Associação Médica Brasileira 63:9, pages 727-728.
Crossref
Crossref
Rinaldo Florencio‐Silva, Ricardo Santos Simões, João Henrique Rodrigues Castello Girão, Adriana Aparecida Ferraz Carbonel, Cristiane de Paula Teixeira & Gisela Rodrigues da Silva Sasso. (2017) Tratamento da atrofia vaginal da mulher na pós‐menopausa. Reprodução & Climatério 32:1, pages 43-47.
Crossref
Crossref
Anne A. Eaton, Raymond E. Baser, Barbara Seidel, Cara Stabile, Jocelyn P. Canty, Deborah J. Goldfrank & Jeanne Carter. (2017) Validation of Clinical Tools for Vaginal and Vulvar Symptom Assessment in Cancer Patients and Survivors. The Journal of Sexual Medicine 14:1, pages 144-151.
Crossref
Crossref
Miranda A. Farage, Kenneth W. Miller & William J. Ledger. 2017. Textbook of Aging Skin. Textbook of Aging Skin
2003
2013
.
Prem K. Pahwa & Sallie M. Foley. 2017. The Textbook of Clinical Sexual Medicine. The Textbook of Clinical Sexual Medicine
79
94
.
Alessandra Graziottin & Filippo MurinaAlessandra Graziottin & Filippo Murina. 2017. Vulvar Pain. Vulvar Pain
129
148
.
Alessandra Graziottin & Filippo MurinaAlessandra Graziottin & Filippo Murina. 2017. Vulvar Pain. Vulvar Pain
9
18
.
Prof. Rossella E. Nappi, Laura Cucinella, Silvia Martella, Margherita Rossi, Lara Tiranini & Ellis Martini. (2016) Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas 94, pages 87-91.
Crossref
Crossref
J. Patterson, L. Millheiser & M. L. Krychman. (2016) Moisturizers, Lubricants, and Vulvar Hygiene Products: Issues, Answers, and Clinical Implications. Current Sexual Health Reports 8:4, pages 213-221.
Crossref
Crossref
Terry M Silvestrin, Anna W Steenrod, Karin S Coyne, David E Gross, Canan B Esinduy, Angela B Kodsi, Gayle J Slifka, Lucy Abraham, Anna L Araiza, Andrew G Bushmakin & Xuemei Luo. (2016) An approach to improve the care of mid-life women through the implementation of a Women’s Health Assessment Tool/Clinical Decision Support toolkit. Women's Health 12:5, pages 456-464.
Crossref
Crossref
Rossella E. Nappi, Santiago Palacios, Martire Particco & Nick Panay. (2016) The REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 91, pages 81-90.
Crossref
Crossref
Rossella E. Nappi, Martire Particco, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2016) Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey. Maturitas 91, pages 74-80.
Crossref
Crossref
Rossella E. Nappi, Chiara Benedetto, Federica Campolo, Silvia Martella, Claudia Tosti, Antonio Cianci, Salvatore Caruso, Secondo Guaschino, Eva Grimaldi, Massimo Bagolan & Marco Sardina. (2016) Efficacy, tolerability and safety of a new medical device, Monurelle Biogel ® vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age. European Journal of Obstetrics & Gynecology and Reproductive Biology 203, pages 82-88.
Crossref
Crossref
Joanie Mercier, Mélanie Morin, Marie-Claude Lemieux, Barbara Reichetzer, Samir KhaliféChantale Dumoulin. (2016) Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study. Menopause 23:7, pages 816-820.
Crossref
Crossref
Terry Silvestrin, Anna Steenrod, Karin Coyne, David Gross, Canan Esinduy, Angela Kodsi, Gayle Slifka, Lucy Abraham, Anna Araiza, Andrew Bushmakin & Xuemei Luo. (2016) Outcomes of Implementing the Women's Health Assessment Tool and Clinical Decision Support Tool Kit. Women's Health 12:3, pages 313-323.
Crossref
Crossref
Seth D. Cohen, Steven Mandel & David B. Samadi. (2016) Assessing Sexual Dysfunction Part 2: Female Sexual Dysfunction. Guides Newsletter 21:3, pages 3-8.
Crossref
Crossref
David D. Rahn. (2016) Refinement and expansion of a tool for measuring genitourinary syndrome of menopause. Menopause 23:4, pages 355-356.
Crossref
Crossref
Antonio Aversa, Mariano Galdiero, Laura Cucinella & Rossella E. Nappi. (2016) La sessualità nell’anziano. L'Endocrinologo 17:2, pages 97-106.
Crossref
Crossref
Mary M. Hunter, Sanae Nakagawa, Stephen K. Van Den Eeden, Miriam Kuppermann & Alison J. Huang. (2016) Predictors of impact of vaginal symptoms in postmenopausal women. Menopause 23:1, pages 40-46.
Crossref
Crossref
F. Palma, A. Volpe, P. Villa & A. Cagnacci. (2016) Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas 83, pages 40-44.
Crossref
Crossref
Kannan Athreya. (2015) Fractional laser rejuvenation of the vagina is a valuable restorative treatment. Journal of Aesthetic Nursing 4:10, pages 490-492.
Crossref
Crossref
Santiago Palacios, Camil Castelo-Branco, Heather Currie, Velja Mijatovic, Rossella E. Nappi, James Simon & Margaret Rees. (2015) Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas 82:3, pages 308-313.
Crossref
Crossref
Peter Chedraui & Faustino R. Pérez-López. (2015) Assessing sexual problems in women at midlife using the short version of the female sexual function index. Maturitas 82:3, pages 299-303.
Crossref
Crossref
Alessandra Graziottin & H. San Raffaele Resnati. (2015) Unmet needs in VVA. Maturitas 82:3, pages 320-321.
Crossref
Crossref
AHINOAM LEV-SAGIE. (2015) Vulvar and Vaginal Atrophy. Clinical Obstetrics & Gynecology 58:3, pages 476-491.
Crossref
Crossref
Camil Castelo-Branco, Nicoletta Biglia, Rossella E. Nappi, Anne Schwenkhagen & Santiago Palacios. (2015) Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection. Maturitas 81:4, pages 462-469.
Crossref
Crossref
Sallie Foley. (2015) Older Adults and Sexual Health: A Review of Current Literature. Current Sexual Health Reports 7:2, pages 70-79.
Crossref
Crossref
Antonino Perino, Alberto Calligaro, Francesco Forlani, Corrado Tiberio, Gaspare Cucinella, Alessandro Svelato, Salvatore Saitta & Gloria Calagna. (2015) Vulvo-vaginal atrophy: A new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 80:3, pages 296-301.
Crossref
Crossref
David F. Archer. (2015) Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy. The Journal of Steroid Biochemistry and Molecular Biology 145, pages 139-143.
Crossref
Crossref
Miranda A. Farage, Kenneth W. Miller & William J. Ledger. 2014. Textbook of Aging Skin. Textbook of Aging Skin
1
13
.
David J. Portman, Margery L.S. Gass & Vulvovaginal Atrophy Terminology Consensus Conference Panel. (2014) Genitourinary Syndrome of Menopause: New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. The Journal of Sexual Medicine 11:12, pages 2865-2872.
Crossref
Crossref
D.J. Portman & M.L.S. Gass. (2014) Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Maturitas 79:3, pages 349-354.
Crossref
Crossref
David J. Portman & Margery L.S. Gass. (2014) Genitourinary syndrome of menopause. Menopause 21:10, pages 1063-1068.
Crossref
Crossref
Stefano Salvatore, Umberto Leone Roberti Maggiore, Massimo Origoni, Marta Parma, Lavinia Quaranta, Filomena Sileo, Alice Cola, Ilaria Baini, Simone Ferrero, Massimo Candiani & Nicola Zerbinati. (2014)
Microablative Fractional CO
2
Laser Improves Dyspareunia Related to Vulvovaginal Atrophy: A Pilot Study
. Journal of Endometriosis and Pelvic Pain Disorders 6:3, pages 150-156.
Crossref
Crossref
Claudine Domoney. (2014) Treatment of Vaginal Atrophy. Women's Health 10:2, pages 191-200.
Crossref
Crossref